Centre de Regulacio Genomica:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centre de Regulacio Genomica - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9426
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre de Regulacio Genomica (CRG) is a biomedical institute that offers healthcare research services. The institute offers research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers light microscopy unit, bioinformatics unit, biomolecular screening, protein technologies unit, and other facilities. CRG operates units for genomics, histology and scientific information technologies. The institute offers courses for undergraduates, PhD students, postdoctoral, researchers and scientists. It also provides technology transfer services. CRG is headquartered in Barcelona, Spain.

Centre de Regulacio Genomica – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Centre de Regulacio Genomica Enters into Agreement with EUGIN Clinic 10
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 11
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 12
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 13
Centre de Regulacio Genomica – Key Competitors 14
Centre de Regulacio Genomica – Key Employees 15
Centre de Regulacio Genomica – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Jan 02, 2018: New approaches in genomic medicine: A step forward in Parkinson’s disease 17
Dec 19, 2017: New approaches in medical genomics: A step forward in Parkinson’s disease 18
Product News 19
Jul 10, 2018: Big Data analysis identifies new cancer risk genes 19
Jun 05, 2018: New tool enables big-scale analysis of single cells 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Key Facts 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre de Regulacio Genomica, Deals By Therapy Area, 2012 to YTD 2018 8
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre de Regulacio Genomica Enters into Agreement with EUGIN Clinic 10
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 11
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 12
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 13
Centre de Regulacio Genomica, Key Competitors 14
Centre de Regulacio Genomica, Key Employees 15

List of Figures
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centre de Regulacio Genomica:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tokyo Electric Power Company Holdings Incorporated (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Incorporated (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Lonrho Ltd:企業のM&A・事業提携・投資動向
    Lonrho Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lonrho Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Fastenal Co:企業の戦略・SWOT・財務情報
    Fastenal Co - Strategy, SWOT and Corporate Finance Report Summary Fastenal Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Jordan Phosphate Mines Co. Plc.:企業の戦略・SWOT・財務情報
    Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report Summary Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Russian Aircraft Corporation MiG JSC:企業の戦略・SWOT・財務情報
    Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report Summary Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Amil Assistencia Medica Internacional S/A:企業の戦略・SWOT・財務情報
    Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report Summary Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Empyrean Energy PLC (EME):企業の財務・戦略的SWOT分析
    Summary Empyrean Energy PLC (Empyrean Energy) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company's projects include China Block 29/11 project, Duyung PSC project, and Sacramento Basin Projects. Its Duyung PSC project covers a …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務分析
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • G-III Apparel Group Ltd (GIII):企業の財務・戦略的SWOT分析
    Summary G-III Apparel Group, Ltd. (G-III or “the company”) is an apparel and footwear manufacturing company. The company designs, manufactures and markets outerwear, dresses, sportswear, swimwear, women's suits and performance wear, luggage, footwear, and women's handbags, leather goods, and cold we …
  • ArjoHuntleigh AB-医療機器分野:企業M&A・提携分析
    Summary ArjoHuntleigh AB (ArjoHuntleigh), a subsidiary of Getinge AB is a medical device company that offers hospital equipment. The company provides integrated solutions to help people affected by reduced mobility and make them self-sufficient. Its products include disinfection and hygiene systems, …
  • Ryerson Holding Corp:戦略・SWOT・企業財務分析
    Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report Summary Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ceragon Networks Ltd (CRNT):企業の財務・戦略的SWOT分析
    Ceragon Networks Ltd (CRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ChemRar High-Tech Center:製薬・医療:M&Aディール及び事業提携情報
    Summary ChemRar High-Tech Center (CHTC) is a developer of drugs for life-threatening diseases. The company offers drugs for the treatment of cancer, central nervous system, infectious, metabolic and cardiovascular diseases. It also offers pre-clinical and clinical research of new molecules including …
  • Bank Of The Philippine Islands
    Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufactur …
  • Nestle (Malaysia) Bhd:企業の戦略・SWOT・財務情報
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Wright Medical Group NV (WMGI):医療機器:M&Aディール及び事業提携情報
    Summary Wright Medical Group NV (Wright) is a medical device company which focuses on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and hand; foot and ankle products. It a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆